text:
GRANBURY — The historic Granbury Opera House has become a construction zone.The lobby, with new curved staircases and a revamped box office, remains a work in progress.Inside, the stage is bare and a crane sits in one corner where seats, now stored in a warehouse, would normally reside.While plenty of work remains, officials say the 127-year-old facility should be finished in time for a black-tie gala Dec. 5 and the opening of A Christmas Carol on Dec. 6, an early holiday gift to North Texas theater patrons."We'll be ready to go," said Andrew Barrus, executive director of the Granbury Theatre Company, which is leasing the opera house from the city. "You should have seen what it looked like a month ago. We've made tremendous progress."The opera house, which was finished in 1886, has been dark for nearly two years as a much-needed makeover began. Granbury set aside $1.2 million in bond funds, but the cost grew to $3.4 million.Many of the improvements will be backstage, where rehearsal spaces, dressing rooms, and places to build and store sets are being added to replace a Quonset hut that has been torn down. The goal is to keep the opera house's intimate feel — its capacity grew by only one seat, to 309 — where everyone is close to the stage. Despite state-of-the-art technology, the opera house will retain a rustic feel, with its exposed limestone walls and pressed-tin ceiling.The cost has generated criticism — some City Council candidates have raised it as an issue in a Hood County News candidate survey — but city officials insist that the renovation will be worth the investment."We think the opera house will dramatically help our tourism," Granbury City Manager Wayne McKethan said. "We see it as a complement to the lake that will bring more people to Granbury."'The square is hopping'With the opera house's reopening, Granbury hopes to see history repeat itself.After closing in 1911 and remaining dark for 64 years, the opera house came back to life in 1975. Jo Ann Miller, who toured with the Tommy Dorsey band and performed on Broadway, led the effort to resurrect the dilapidated theater.She ran the house for two decades as busloads of theatergoers from across North Texas flocked to Granbury to watch family-friendly productions, taking time to shop and grab a bite on the quaint downtown square.After Miller was pushed aside by opera house board members in 1995, the theater began to have financial troubles. In 2006, the city assumed ownership. "We had a director from New York and incurred a substantial amount of debt," said Lisa Johnson, a former Granbury City Council member. "To avoid it closing, the city took over the theater." Barrus, who started the Granbury Theatre Company in 2011 after working for Cirque Du Soleil in China, has been staging plays at the vacant Granbury Live building, also on the courthouse square. He said there is definitely an audience for live theater in the town about 40 miles southwest of Fort Worth. "When the shows are going on Thursday, Friday, Saturday, the square is hopping," Barrus said. "When they aren't on Monday, Tuesday, Wednesday, it is not."Bringing culture to TexasWhile opera houses are now fairly rare in Texas towns, they were once a sign of a shift toward a more cultured society as several hundred sprang up across the state between the late 1800s and World War I.A Texas historical marker in the Central Texas town of Lampasas sums up the opera house era: "Every major town had one, and opera companies from San Francisco, Chicago, and Cincinnati made annual tours, sometimes playing a town two weeks. Opera houses also helped curb the influence of theaters and music halls, whose public reputation unfortunately matched that of the saloons and gambling houses."But opera houses waned in the early 20th century as movies and radio took over as the most popular forms of entertainment.The Granbury Opera House was originally known as Kerr's Opera House and occupied only the second floor of the building. "Vaudeville acts, dramatic productions, and musical programs occupied the top floor until 1911," according to a state historical marker. "The lower floor housed various businesses, including a saloon, saddle and harness shop, and two grocery stores. Later the roof collapsed, and the building rapidly deteriorated."Not happy with costsOnce it reopens, supporters say, the theater will be used for a multitude of purposes. There will be a children's theater company, and they hope to have a lecture series. Ballet and symphony performances and the occasional live concert haven't been ruled out."It's going to be an evolution," Councilman Gary Couch said. "We don't know today all of the potential. That will build over time."Couch, elected in November, believes that he was voted into office to push the stalled renovation forward."The people who supported me in the election wanted to see this project come through," Couch said.Councilman Tony Allen, who voted for the renovation, said he has heard from residents troubled by the soaring costs. "I believe a lot of people in Granbury are upset," he said.The opera house needed renovations to comply with the Americans With Disabilities Act and to add more restrooms. The work was designed by Schwarz-Hanson Architects of Fort Worth, and the contractor is Scott Tucker Construction of Fort Worth.Design changes that added costs included an orchestra pit and a 5,000-square-foot backstage extension. Under the original plans, the extension would have been built but finished out later.While Allen has cost concerns, he said the venue will be an asset for Granbury."It's going to be the nicest little opera house in Texas for a city of our size," Allen said. "I'm proud of that, but I'm not proud of the spending."A small version of Bass Hall?Scott Young, president of the Historic Granbury Merchants Association, said the opera house will be a boon to merchants on the square but will also benefit the entire Hood County area."We have what Bass Hall has — we just don't have as many seats," Young said. "… If you look across the board, generally some governmental entity supports the arts. In the case of the opera house, it's historic first but secondly it's significant to our economy."The city started a fundraising campaign last week in the hope of securing $1 million in donations to offset some of the cost. McKethan, the city manager, said the city has received pledges of about $150,000. Parts of the opera house will have naming rights for everything from seats to the hall and the stage. Naming rights will range from $500 for a seat to $500,000 for the performance hall and stage. The support will be there, Couch said, once the renovation is finished."Once this is complete and they walk through it, I think they will be on board when they see what we've done," Couch said.
Bill Hanna, 817-390-7698 Twitter: @fwhanna


text:
Living in California, you know that there are always bugs around, but it can be unbearable when they have taken up refuge in your home or place of business. You may have fought with them for years trying to keep them out of your home, and maybe your ready to let the pros take over. If you are looking for some one to handle your pest control in Sacramento, here are a few tips and pointers that will help you find the perfect service for your needs.
Finding the Right Company
With so many services in the area, finding the right one might seem like an impossible task. It's actually a lot easier than you may think, and with the internet at your fingertips it just got a lot easier. A quick internet search will bring you back a lot of companies to choose from, and here is what to look for in each company. The first thing you want to do is find a company with a lot of experience; the more experience they have working in your local area, the better they are going to know what kinds of treatments work with what kinds of bug problems. Professionalism, this is very important, the more professional a company acts the better your service will be, they will treat you well and you wont have a lot of problems with them. A good indicator of how well a company treats their clients is to read through their testimonials page on their website, these past and current customer reviews will show you how they treat their clients. The last thing that you want to check is the service the company provides, finding a company that offers what you need will help you cut down your list.
Setting up the Consultation
Once you have some internet research on a few different companies, call the one that you like the most and have them come to your home or place of business to look at your bug problem. While they are out there they will be able to see what they will need to do to free your space of bugs, and they will be able to give you an estimate for the services. After you have had a few companies out you will be able to make a better decision. You may also want to take the chance to ask them what they use in the solutions that they will be spraying around your home. If you have small children or pets you should ask what precautions to take. So look around at the local services and use these guidelines to pick your perfect pest control in Sacramento, and say good-bye to all those bugs that have invaded your home.

subset: commoncrawl


text:
DENVER (AP) - Police in Washington say a man whose body was found in an alley was a 66-year-old Denver resident who had been visiting the nation's capital.
KUSA-TV in Denver reports ( http://on9news.tv/IMOPBe) Gary Dederichs had worked as a registered nurse in the Denver area. Officers say he had head injuries when he was found Tuesday. They are investigating his death as a homicide.
Police say he was killed near the rental property where he had been staying during his visit.
Information from: KUSA-TV, http://www.9news.com
(Copyright 2012 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.)


text:
Quotes & Info
|MNTA > SEC Filings for MNTA > Form 10-Q on 8-Nov-2013
|All Recent SEC Filings
Quarterly Report
Our Management's Discussion and Analysis of Financial Condition and Results of Operations includes the identification of certain trends and other statements that may predict or anticipate future business or financial results. There are important factors that could cause our actual results to differ materially from those indicated. See "Risk Factors" in Item 1A of Part II of this Quarterly Report on Form 10-Q.
Statements contained or incorporated by reference in this Quarterly Report on
Form 10-Q that are not based on historical fact are "forward-looking statements"
within the meaning of the Private Securities Litigation Reform Act of 1995,
Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements regarding future events and our future results are based on current expectations, estimates, forecasts, projections, intentions, goals, strategies, plans, prospects and the beliefs and assumptions of our management including, without limitation, our expectations regarding results of operations, general and administrative expenses, research and development expenses, current and future development and manufacturing efforts, regulatory filings, nonclinical and clinical trial results, the outcome of litigation and the sufficiency of our cash for future operations. Forward-looking statements can be identified by terminology such as "anticipate," "believe," "could," "could increase the likelihood," "hope," "target," "project," "goals," "potential," "predict," "might," "estimate," "expect," "intend," "is planned," "may," "should," "will," "will enable," "would be expected," "look forward," "may provide," "would" or similar terms, variations of such terms or the negative of those terms.
We cannot assure investors that our assumptions and expectations will prove to have been correct. Important factors could cause our actual results to differ materially from those indicated or implied by forward-looking statements. Such factors that could cause or contribute to such differences include those factors discussed below under "Risk Factors" in Item 1A of Part II of this Quarterly Report on Form 10-Q. We undertake no intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.
The Company
We are a biotechnology company specializing in the structural characterization, process engineering and biologic systems analysis of complex molecules such as polysaccharides, polypeptides, and biologics (including proteins and antibodies). Our initial technology was built on the ability to characterize complex polysaccharides. Over the last decade, we have expanded our expertise into technologies that enable us to develop a diversified product portfolio of complex generics, biosimilars and novel products. Our business strategy has been to develop both generic and novel products, and we are working with collaborators to develop and commercialize our complex generics and biosimilars. This strategy was validated by the marketing approval and commercial launch of Enoxaparin Sodium Injection, a generic version of Lovenox®, in July 2010. Since its launch through September 30, 2013, we have recorded Enoxaparin Sodium Injection product revenues of approximately $434 million, driven primarily by its initial status as a sole generic. We believe that our scientific capabilities, engineering approaches, intellectual property and regulatory strategies, and synergistic business model position us to develop and commercialize competitively differentiated products in our target areas of complex generics, biosimilars and novel products.
As of September 30, 2013, we had an accumulated deficit of $240.4 million. To date, we have devoted substantially all of our capital resource expenditures to the research and development of our product candidates. In the second half of 2010, we began to derive revenue from our profit share on Sandoz's commercial sale of Enoxaparin Sodium Injection. Due to the launch by Actavis and Amphastar of their enoxaparin product in January 2012, our Enoxaparin Sodium Injection product revenue has significantly decreased and we have been incurring operating losses. We expect that our return to profitability, if at all, will most likely come from the commercialization of our generic Copaxone product, which is subject to FDA approval. Unless and until generic Copaxone is approved, we expect to incur annual operating losses over the next several years as we expand our drug commercialization, development and discovery efforts. Additionally, we plan to continue to evaluate possible acquisitions or licensing of rights to additional technologies, products or assets that fit within our growth strategy. Accordingly, we will need to generate significant revenue to return to profitability.
Our Programs
Our complex generics programs target marketed products that were originally approved by the United States Food and Drug Administration, or FDA, as New Drug Applications, or NDAs. Therefore, we have been able to access the existing 505(j) generic regulatory pathway and have submitted Abbreviated New Drug Applications, or ANDAs, for these products. Our first commercial product, Enoxaparin Sodium Injection, which has been developed and commercialized in collaboration with Sandoz Inc. and Sandoz AG, collectively Sandoz, affiliates of Novartis AG, received FDA marketing approval in July 2010 as a generic version of Lovenox® (enoxaparin sodium injection). Lovenox is a complex mixture of polysaccharide chains derived from naturally sourced heparin which is used to prevent and treat deep vein thrombosis, or DVT, and to support the treatment of acute coronary syndromes, or ACS. The Enoxaparin Sodium Injection ANDA submitted by Sandoz was the first ANDA for a generic Lovenox to be approved by FDA, validating our novel approaches to the structural characterization, process engineering and biologic systems analysis of complex molecules. From July 2010 through early October 2011, the Enoxaparin Sodium Injection marketed by Sandoz was
the sole generic version of Lovenox, and consequently, under the terms of our collaborative agreement with Sandoz, we earned 45% profit share on Sandoz's sales of Enoxaparin Sodium Injection. The product now faces other generic competitors and we receive a royalty on net sales, which have been significantly eroded by competitive pressures.
Our second complex generic product candidate, M356, is designed to be a generic version of Copaxone® (glatiramer acetate injection), a drug that is indicated for the reduction of the frequency of relapses in patients with relapsing-remitting multiple sclerosis, or RRMS. Copaxone consists of a synthetic mixture of polypeptide chains. With M356, we extended our core polysaccharide characterization and process engineering capabilities to develop capabilities for the structural characterization, process engineering and biologic systems analysis of this complex polypeptide mixture. We are also collaborating with Sandoz to develop and commercialize M356, and the Sandoz ANDA for M356 is currently under FDA review.
Our biosimilars program is targeted toward developing biosimilar versions of marketed therapeutic proteins, with a goal of obtaining FDA designation as interchangeable. The subset of biosimilars receiving an interchangeability designation are known as interchangeable biologics. In March 2010, an abbreviated regulatory process was codified in Section 351(k) of the Patient Protection and Affordable Care Act of 2010. This new pathway opens the market for biosimilar and interchangeable versions of a broad array of biologic therapeutics, including antibodies, cytokines, fusion proteins, hormones and other recombinant proteins. Forecasters predict a rapidly growing multi-billion dollar global market for these products. Most of these biologics are complex mixtures, and for several years we have been investing in developing novel approaches to the structural characterization, process engineering and analysis of the biologic activities of these products. In February 2012, FDA released three documents containing their preliminary guidelines for applications under the Section 351(k) pathway. These guidelines state that FDA will use a step-wise review that considers the totality-of-the-evidence in determining extent of the clinical development program. This approach puts a substantial emphasis on structural and functional characterization data in evaluating biosimilar products for approval. We believe the framework that the FDA has outlined in the draft guidance documents aligns with our strategy for biosimilars. Our goal is to engineer biologic products that would justify a selective and targeted approach to human clinical testing and to support demonstration of interchangeability. In December 2011, we and Baxter International, Inc., Baxter Healthcare Corporation and Baxter Healthcare SA, collectively, Baxter, entered into a global collaboration and license agreement, or the Baxter Agreement, to develop and commercialize up to six biosimilars. The Baxter Agreement became effective in February 2012. Baxter is an established healthcare company with global product development, manufacturing and commercial capabilities.
Our novel products program leverages the capabilities and expertise of our complex generics and biosimilars programs to address unmet clinical needs. Our most advanced efforts have been in the area of polysaccharide mixtures. M402, in Phase 1 clinical development as a potential anti-cancer agent, is a novel heparan sulfate mimetic that binds to multiple growth factors, adhesion molecules and chemokines to inhibit tumor angiogenesis, progression, and metastasis. In addition to this development candidate, we are also seeking to discover and develop additional novel products. Our goal is to leverage the multi-targeting nature of complex mixture molecules to develop novel products which could positively modulate multiple pathways in a disease. We have built significant capabilities in biological characterization and engineering of proteins through our biosimilars platform that provide us with the potential to create unique and novel formulations of protein (including antibody) drug compositions for specific disease indications. To add to these capabilities, in December 2011 we acquired selected assets of Virdante Pharmaceuticals, Inc. relating to sialylation technology. Sialic acid is a type of sugar modification on selected proteins that is understood to regulate anti-inflammatory and immunomodulatory function. These assets add to our core ability to modify and engineer protein backbones to precisely regulate biological networks and develop novel biologic product candidates. We are applying our proprietary sialylation technology program to develop a sialylated plasma-derived intravenous immunoglobulin, or IVIG, product, or a recombinant sialylated Fc product. We continue to generate data to investigate and validate the biology of sialylated IVIG/Fc in order to define the specific product, or products, to potentially advance to the clinic, as well as, to inform our selection of the indication to potentially take forward into development. We continue to investigate both approaches, and expect to have data later this year that will help guide our development efforts.
Our Collaborations
In 2003, we entered into a collaboration and license agreement, or the 2003 Sandoz Collaboration, with Sandoz N.V. and Sandoz Inc. to jointly develop, manufacture and commercialize Enoxaparin Sodium Injection in the United States. Sandoz N.V. later assigned its rights in the 2003 Sandoz Collaboration to Sandoz AG, an affiliate of Novartis Pharma AG. We refer to Sandoz AG and Sandoz Inc. together as Sandoz.
In 2006 and 2007, we entered into a series of agreements, including a Stock Purchase Agreement and an Investor Rights Agreement, with Novartis Pharma AG, and a collaboration and license agreement, as amended, or the Second Sandoz Collaboration Agreement, with Sandoz AG. Together, this series of agreements is referred to as the 2006 Sandoz Collaboration. Under the Second Sandoz Collaboration Agreement, we and Sandoz AG expanded the geographic markets for Enoxaparin Sodium Injection covered by the 2003 Sandoz Collaboration to include the European Union. Further, under the Second Sandoz Collaboration Agreement, we and Sandoz AG agreed to exclusively collaborate on the development and commercialization of M356, among other products. In connection with the 2006 Sandoz Collaboration, we sold 4,708,679 shares of common stock to Novartis Pharma AG at a per share price of $15.93 (the closing price of our common stock on the NASDAQ Global Market was $13.05 on the date of purchase) for an aggregate purchase price of $75.0 million, resulting in an equity premium of $13.6 million. As of September 30, 2013, Novartis AG owned approximately 9% of our outstanding common stock.
Prior to the launch of Enoxaparin Sodium Injection in 2010, the collaboration revenues derived from our 2003 Sandoz Collaboration and 2006 Sandoz Collaboration primarily consisted of amounts earned by us for reimbursement by Sandoz of research and development services and development costs. In July 2010, Sandoz began the commercial sale of Enoxaparin Sodium Injection. The profit-share or royalties Sandoz is
obligated to pay us under the 2003 Sandoz Collaboration differ depending on whether (i) there are no third-party competitors marketing an interchangeable generic version of Lovenox, or Lovenox-Equivalent Product (as defined in the 2003 Sandoz Collaboration), (ii) a Lovenox-Equivalent Product is being marketed by Sanofi-Aventis, which distributes the brand name Lovenox, or licensed by Sanofi-Aventis to another company to be sold as a generic drug, both known as authorized generics, or (iii) there are one or more third-party competitors which are not Sanofi-Aventis marketing a Lovenox-Equivalent Product. From July 2010 through September 2011, no third-party competitor was marketing a Lovenox-Equivalent Product; therefore, during that period, Sandoz paid us 45% of the contractual profits from the sale of Enoxaparin Sodium Injection. In September 2011, FDA approved the ANDA for the enoxaparin product of Amphastar Pharmaceuticals, Inc. or Amphastar. In October 2011, Sandoz confirmed that an authorized generic Lovenox-Equivalent Product was being marketed, which meant that Sandoz was obligated to pay us a royalty on its net sales of Enoxaparin Sodium Injection until the contractual profits from those net sales in a product year (July 1-June 30) reached a certain threshold. Upon the achievement of the contractual profit threshold in December 2011, Sandoz was obligated to pay us a profit share for the remainder of the product year. In January 2012, following the Court of Appeals for the Federal Circuit granting a stay of the preliminary injunction previously issued against them by the United States District Court, Watson Pharmaceuticals, Inc. (now Actavis, Inc., or Actavis) and Amphastar launched their third-party competitor enoxaparin product. Consequently, in each product year, for net sales of Enoxaparin Sodium Injection up to a pre-defined sales threshold, Sandoz is obligated to pay us a royalty on net sales payable at a 10% rate, and for net sales above the sales threshold, payable at a 12% rate.
Certain development and legal expenses may reduce the amount of profit-share, royalty and milestone payments paid to us by Sandoz. Any product liability costs and certain other expenses arising from patent litigation may also reduce the amount of profit-share, royalty and milestone payments paid to us by Sandoz, but only up to 50% of these amounts due to us from Sandoz each quarter. Our contractual share of these development and legal expenses is subject to an annual adjustment at the end of each product year, and ends with the product year ending June 2015. The third annual adjustment of $3.8 million was recorded as a reduction in product revenue in the three and six months ended June 30, 2013.
In December 2011, we and Baxter entered into the Baxter Agreement under which we agreed to collaborate, on a world-wide basis, on the development and commercialization of up to six biosimilars. The Baxter Agreement became effective in February 2012. Baxter is an established healthcare company with global product development, manufacturing and commercial capabilities. To accelerate efforts in the biosimilars space and address this growing global market, we significantly increased the headcount and related operating expenses dedicated to our biosimilars program in 2012 and this trend has continued in 2013. We expect that the increase in operating expenses will be partially offset in future years by revenues from option fees and milestone payments under the Baxter Agreement, subject to achievement of technical and regulatory criteria. We have announced the following three products in development under the Baxter Agreement:
† M923, a biosimilar for a branded biologic indicated for autoimmune and inflammatory disease, is our most advanced biosimilar. We are working towards an Investigational New Drug, or IND, submission, which is targeted for the second half of 2014.
† M834, also indicated for autoimmune and inflammatory disease. We are working toward achievement of a pre-defined "minimum development criteria" license payment in 2014.
† M511, a monoclonal antibody for oncology. We are working toward achievement of a pre-defined "minimum development criteria" license payment in 2014.
Our revenue has been primarily derived from our 2003 Sandoz Collaboration and 2006 Sandoz Collaboration. In 2012, we began recognizing revenue under the Baxter Agreement. In the near term, our current and future revenues are dependent upon the continued successful commercialization of Enoxaparin Sodium Injection, license fees and milestone payments earned under the Baxter Agreement and potential profit share payments and milestones from our 2006 Sandoz Collaboration. In the longer term, our revenue growth will depend upon the successful clinical development, regulatory approval and launch of new commercial products and the pursuit of external business development opportunities. We expect that any revenue we generate will fluctuate from quarter to quarter as a result of the amount and timing of revenue we earn under our collaborative or strategic relationships.
Research and Development
Research and development expenses consist of costs incurred in identifying, developing and testing product candidates. These expenses consist primarily of salaries and related expenses for personnel, license fees, consulting fees, nonclinical and clinical trial costs, contract research and manufacturing costs, and the costs of laboratory equipment and facilities. We expense research and development costs as incurred. Due to the variability in the length of time necessary to develop a product, the uncertainties related to the estimated cost of the projects and ultimate ability to obtain governmental approval for commercialization, accurate and meaningful estimates of the ultimate cost to bring our product candidates to market are not available.
Product Programs- Complex Generics and Biosimilars
Enoxaparin Sodium Injection-Generic Lovenox®
Enoxaparin Sodium Injection, our first product to receive marketing approval under an ANDA, is a generic version of Lovenox®. Lovenox is a complex drug consisting of a mixture of polysaccharide chains and is a widely-prescribed low molecular weight heparin, or LMWH, used for the prevention and treatment of DVT and to support the treatment of ACS. Lovenox is distributed worldwide by Sanofi-Aventis U.S. LLC, or Sanofi-Aventis, and is also known outside the United States as Clexane® and Klexane®. Under our 2003 Sandoz Collaboration, we work with Sandoz exclusively to develop, manufacture and commercialize Enoxaparin Sodium Injection in the United States. Sandoz is responsible for funding substantially all of the United States-related Enoxaparin Sodium Injection development, regulatory, legal and commercialization costs, other than legal expenses incurred by each party in connection with the patent suits filed against Teva Pharmaceutical Industries Ltd., or Teva, in December 2010 and Amphastar Pharmaceuticals, Inc., or Amphastar, Actavis, Inc., or Actavis, and International Medical Systems, Ltd. (a wholly owned subsidiary of Amphastar) in September 2011. In these cases, Momenta and Sandoz each bear their own legal expenses.
Sandoz submitted ANDAs in its name to the FDA for Enoxaparin Sodium Injection in syringe and vial forms, seeking approval to market Enoxaparin Sodium Injection in the United States. The ANDA for the syringe form of Enoxaparin Sodium Injection was approved in July 2010 and the ANDA for the vial form of Enoxaparin Sodium Injection was approved in December 2011.
In September 2011, we and Sandoz sued Amphastar, Actavis and International Medical Systems, Ltd. in the United States District Court for the District of Massachusetts for infringement of two of our patents. Also in September 2011, we filed a request for a temporary restraining order and preliminary injunction to prevent Amphastar, Actavis and International Medical Systems, Ltd. from selling their enoxaparin sodium product in the United States. In October 2011, the District Court granted our motion for a preliminary injunction and entered an order enjoining Amphastar, Actavis and International Medical Systems, Ltd. from advertising, offering for sale or selling their enoxaparin product in the United States until the conclusion of a trial on the merits and requiring us and Sandoz to post a security bond of $100 million in connection with the litigation. Amphastar, Actavis and International Medical Systems, Ltd. appealed the decision to the Court of Appeals for the Federal Circuit, or CAFC, and in January 2012, the CAFC stayed the preliminary injunction. In June 2012, Amphastar filed a motion to increase the amount of the security bond, which we and Sandoz have opposed. In August 2012, the CAFC issued a written opinion vacating the preliminary injunction and remanding the case to the District Court, holding that Amphastar's use of our patented method for processing Enoxaparin Sodium Injection was protected by the "safe harbor" from patent infringement under federal patent law, 35 U.S.C. Section 271(e)(1). In September 2012, we filed a petition with the CAFC for rehearing by the full court en banc, which was denied. In February 2013, we filed a petition for a writ of certiorari for review of the CAFC decision by the United States Supreme Court and in June 2013 the Supreme Court denied the request.
In January 2013, Amphastar and Actavis filed a motion for summary judgment in the District Court following the decision from the CAFC and on July 19, 2013, the District Court granted the motion for summary judgment. We have filed a protective notice of appeal of the decision to the CAFC, although the District Court has not issued a final judgment as of this filing.
In December 2010, we sued Teva in the United States District Court for the District of Massachusetts for infringement of two of our patents. In January 2013, Teva filed a motion for summary judgment in the District Court following the decision from the CAFC in the aforementioned case and on July 19, 2013, the District Court granted the motion for summary judgment. We have filed a protective notice of appeal of the decision to the CAFC, although the District Court has not issued a final judgment as of this filing.
M356-Generic Copaxone® (glatiramer acetate injection)
M356 is designed to be a generic version of Copaxone ® (glatiramer acetate injection), a complex drug consisting of a synthetic mixture of polypeptide chains. Copaxone is indicated for the reduction of the frequency of relapses in patients with RRMS, a chronic disease of the central nervous system characterized by inflammation and neurodegeneration. In North America, Copaxone is marketed by Teva Neuroscience, Inc., which is a subsidiary of Teva. Under the Second Sandoz Collaboration Agreement, we and Sandoz AG agreed to exclusively collaborate on the development and commercialization of M356, among other products. Under the Second Sandoz Collaboration Agreement, costs, including development costs and the cost of clinical studies, will be borne by the parties in varying proportions, depending on the type of expense. For M356, we are generally responsible for all of the development costs in the United States. For M356 outside of the United States, we share development costs in proportion to our profit sharing interest. All commercialization responsibilities and costs will be borne by Sandoz AG worldwide as they are incurred for all products. We are reimbursed at cost for any external costs incurred in the development of products where development activities are funded solely by Sandoz AG or partly in proportion where development costs are shared between us and Sandoz AG. We are also paid at a contractually specified rate for FTEs performing development services where development activities are funded solely by Sandoz AG or partly by proportion where development costs are shared between us and Sandoz AG. The parties will share profits in varying proportions, depending on the product. Profits on net sales of M356 will be calculated by deducting from net sales the costs of goods sold and an allowance for selling, general and administrative costs, which is a contractual percentage of net sales. Sandoz AG is responsible for funding all of the legal expenses incurred under the Second Sandoz Collaboration Agreement; however a portion of certain legal expenses will be offset against the profit-sharing amounts in proportion to our profit sharing interest.
In December 2007, Sandoz submitted to the FDA an ANDA seeking approval to market our joint product M356 in the United States containing a Paragraph IV certification. This is a certification by the ANDA applicant that the patent relating to the drug product that is the subject of the ANDA is invalid, unenforceable or will not be infringed. In July 2008, the FDA notified Sandoz that it had accepted the ANDA for review
as of December 27, 2007. In addition, the FDA's published database indicates that the first substantially complete ANDA submitted for glatiramer acetate injection containing a Paragraph IV certification was filed on December 27, 2007, making Sandoz's ANDA eligible for the grant of a 180-day generic exclusivity period upon approval. Under applicable laws, there are a number of ways an ANDA applicant may forfeit its 180-day exclusivity. While the FDA will not make any decision regarding the exclusivity period before the date the ANDA is approved, due to the passage of time and the outcome of the Hatch-Waxman litigation with Teva, we do not expect that the 180-day exclusivity will be granted at the time of approval of the ANDA.
Since 2008, Teva has filed four Citizen Petitions with FDA requesting FDA deny approval of any ANDA filed for generic Copaxone. The FDA has denied each of the Citizen Petitions. We anticipate Teva will continue to engage in activities that seek to challenge the approval of our M356 ANDA.
Subsequent to FDA's acceptance of the ANDA for review, in August 2008, Teva and related entities and Yeda Research and Development Co., Ltd., filed suit against us and Sandoz in the United States Federal District Court in the Southern District of New York. The suit alleged infringement related to four of the seven . . .


text:
Loading product details ...
Reviews (0)
Need Help?
Product Description:
Men's Puma® Running 7" Baggy Shorts :: coolCELL fabric wicks away moisture so it can quickly evaporate in combination with ventilation areas for improved air circulation at critical heat zones. Reflective logo and other reflective items for enhanced visibility in low light conditions. Mesh inserts for improved air circulation at critical heat zones. Flatlock stitching for less friction and higher comfort.
You're in luck! Black Friday & Cyber Monday Top Pick - 2014!This item has been picked as a 2014 Black Friday & Cyber Monday Top Product!
Features & Benefits:
Your Help Is Here
Shop with confidence knowing your team of Fit Experts is waiting to answer all your questions. You can always find your perfect product and your perfect fit. Your Road Runner Sports Fit Experts will make sure you get exactly what you want and have tons of fun in the process! Give us a call, chat, or email!
Call 800-743-3206 to
Send us an email and count on a Fit Expert to reply to you as quickly as possible
You May Also Like
More Related Products
Men's Under Armour® Flyweight Run 7" Short :: Ultra light, stretch woven fabric delivers superior mobility Internal mesh liner helps ...
Men's Saucony® Run Lux III Short :: Saucony®'s best selling short! This short is built with a 7" inseam, wicking ...


text:
Vehicle Donation
Thank you for considering the Camellia Symphony Orchestra for your vehicle donation!
Insurance Auto Auctions, Inc. has an excellent reputation in the industry and offers supportive customer service.
Simply call the 800 number below to get the process started. We've also included additional information on the process for your review.
Should you have any questions or comments, please call the CSO office at (916) 929-6655.
Car Donation Program Outline
1. If you're interested in donating your car on behalf of Camellia Symphony, please call Insurance Auto Auctions, Inc. at this number: 1-800-320-0476. This line can be used as an after-hours phone line or during the Holidays.
2. If Insurance Auto Auctions are unable to accept your donation, they will contact you as soon as possible to respectfully decline the donation – usually within 24 hours.
3. If Insurance Auto Auctions are able to accept the donation, a towing agency will call you within 24 to 48 hours to schedule the pick-up. In addition, Vehicle Donation Processing Center will make a customer service call to you on the 4th business day to follow up.
4. The tow driver will distribute your donation receipt at the time of pick-up and Insurance Auto Auctions will need the car, keys and title. You should retain the donation receipt for your records. It is an important document necessary for any available federal income tax deduction.
5. After the car is picked up, Insurance Auto Auctions will sell the vehicle at auction or directly to a salvage yard. They normally receive proceeds from the sale of a vehicle within 60 to 90 days after pick-up. They remit charity proceeds monthly.
6. If the vehicle has a gross sale in excess of $500, Insurance Auto Auctions will send you a completed IRS 1098-C tax form within 30 days of the completed sale. They will also file a year end report to the IRS on all 1098-C tax forms that were provided to your donors in the calendar year.
Please feel free to call the Insurance Auto Auctions customer service center seven days a week at 1-800-320-0476.


text:
Sunday 6 March 2011: Not Cucumbers
"A cucumber should be well sliced, and dressed with pepper and vinegar, and then thrown out as good for nothing."
- Samuel Johnson.
I agree wholeheartedly with Mr Johnson here: cucumber should indeed be dealt with thusly.
These, however, are not cucumbers, and should be dealt with by savage nomming - as they indeed were after mrs tsuken had roasted them to perfection along with a beautiful leg of pork.
- viewed 474 times :
- 9 comments :
- show tags


text:
#Seawolves begin five-game road trip at No. 8 Duke, Iona
Both opponents joined the Seawolves in a national postseason tournament in 2013-14
#Seawolves host Bradley Monday night
Stony Brook is 2-0 at Island Federal Credit Union Arena
Strong second half lifts #Seawolves over Lions, 82-68
Redshirt junior Miranda Jenkins notched her first career double-double with 14 points and 12 rebounds.
Excitement builds as #Seawolves ready for new chapter
Stony Brook will play inaugural season at Island FCU Arena under first-year head coach Caroline McCombs
Stony Brook University Arena ribbon cutting a slam dunk
New $21.1 million arena will be a Long Island hub for athletics and entertainment
Career Highs
Points: 17 (vs. New Hampshire, 2/9/14)
2014-15: Tallied two points, six rebounds and two steals vs. Saint Peter's (11/15)...recorded 14 points and a career-high 12 boards for the first double-double of her career vs. Columbia (11/21/14).
2013-14: Saw action in 30 games and made 27 starts...averaged 7.3 points per game...made first collegiate start and played a career-high 26 minutes vs. NJIT (11/8)...posted a new personal-best of seven points and matched career-highs in minutes (26) and rebounds (4) at Bradley (11/15)...recorded a new career-high five rebounds to go along withtwo assists and two posts at Fairleigh Dickinson (11/21)...tallied a new personal-best of nine points and tied a game-high with three steals vs. Morgan State (11/25)....went 6-for-6 from the line and finished with eight points in a career-high 36 minutes vs. Army (11/29/13)...posted six points and a career-high seven rebounds at Lafayette (12/8)...had four points, four rebounds and two assists vs. Wagner (12/22)...recorded eight points at Seton Hall (12/31)...tallied a career-high 13 points to go along with six boards at Columbia (1/5)...scored 13 points vs. Hartford (1/8)...scored five of her nine points in the final 1:08 of play to lift the Seawolves to a win at Binghamton (1/15)...recorded 10 points and three helpers vs. UMass Lowell (1/18)...tallied seven points vs. UMBC (1/20)...finished with 10 points, four rebounds and two steals at Vermont (1/23)...tallied 10 points, two assists and two steals at Maine (1/26)...scored eight points vs. Binghamton (2/5)...posted a career-high 17 points to go along with five rebounds vs. UNH (2/9)...tallied seven points at UMBC (2/19)...scored 10 points in Stony Brook's 20th win vs. Maine (2/22)...recorded 14 points and a career-high nine boards to help Stony Brook to its Division I-record 21st win of the season vs. Vermont (2/26)...scored nine points as Stony Brook ended Albany's 38-game conference winning streak in a road win (3/1)...tallied seven points and six boards vs. UNH in the America East Semifinals (3/9).
2012-13: Saw action in eight games...scored first collegiate points at Youngstown State on Nov. 30...scored a bucket versus Hartford on Feb. 10...tallied first career assist and steal while chipping in two point at Albany on March 2...knocked down a 3-pointer and played 15 minutes in the America East Quarterfinals vs. UNH on March 8.
2011-12: Redshirted.
High School:Four-time first team all-conference selection at Eastern Guilford High School ... third in school history in scoring (1880 points) ... fourth all-time in rebounding (636 rebounds) ... school record 607 assists ... led Eastern to four straight conference championships ... led Eastern to 85-28 record in her four years there ... named Conference Player of the Year and team MVP as a senior ... 2011 Greensboro News & Record All-Area Player of the Year ... 2011 Burlington Times-News All Region Player of the Year ... two-time Eastern Guilford Female Athlete of the Year ... three-time academic all-conference selection ... earned 2011 Courage Award (given to a player rose above the circumstances) ... named All-State by NCPREPS.com ... set career-highs in points (24.1 ppg), rebounds (6.6 rpg) and steals (4.6 spg) ... led Eastern to 24-4 record and No. 9 state ranking as a junior ... runner up for Conference Player of the Year as a sophomore when she averaged 16.4 points, 6.0 rebounds and 5.7 assists per game ... played AA for Greensboro Galaxy ... led the Galaxy to consecutive regional championships in addition to leading them to the Division II National Championship in 2007.


text:
The Bahá'í House of Worship for North America
The Baha'i House of Worship
100 Linden Ave (Map)
Wilmette, IL 60091
This sacred space is open to all for prayer, quiet contemplation, and spiritual renewal.
Auditorium and Gardens:
Open year round, 6 am-10 pm
Welcome Center
May 15 - September 15, 10 am-8 pm
September 16 - May 14, 10 am-5 pm
(Please note that the Welcome Center will be closed November 15 and 16 for a private event.)
Admission: Free
Services: All are welcome. Brief prayer services are held every day, beginning promptly at 9:15 am and 12:30 pm. Prayers are offered in Spanish on the first Sunday of each month at 1:15 pm. The a cappella House of Worship Choir sings at the 12:30 pm service on the first three Sundays of each month
Introductory Presentation on the Baha'i Faith
An introductory power point presentation on the Baha'i Faith is held every Sunday in the lower level Welcome Center of the Baha'i House of Worship. The presentations begin at 1:00 pm, immediately after the 12:30 pm devotional program that is held in the upstairs auditorium. All are welcome to attend. Call: 847-853-2300 for further information.
Parking and Accessibility
Please note that the main parking lot accessed from Linden Avenue is closed due to construction. The parking lot accessed from Sheridan Road is open. (More info about parking and accessibility) is available on this site or call the House of Worship's Office of Public Safety at: 847-853-2312.)
Bus Accessibility: Bus access to Linden Avenue is currently not permitted.
Buses may load and unload on Sheridan Road at the northwest corner of Linden Avenue and Sheridan Road, with the buses coming from the north, stopping at Linden and Sheridan facing south. (Vehicles over 10 tons are prohibited from crossing the Linden Avenue bridge just west of the House of Worship and, because of construction, it is not possible for buses to turn around in the House of Worship parking lot.)
"Verily, the founding of this temple will mark the inception of the Kingdom of God on earth. It is the evident standard waving in the center of the great continent of America."
"The doors will be open to all sects — no differentiation; and by God's help this temple will prove to be to the body of human society what the soul is to the body of man."— `Abdu'l-Bahá
One of only seven Baha'i temples in the world at present, this unique structure symbolizes unity and invites prayer to God. The quiet serenity of the Baha'i House of Worship reflects the spiritual truths of the Baha'i Faith: the oneness of God, the oneness of humanity and the oneness of religion. Like all Baha'i Houses of Worship, the temple in Wilmette has nine sides and is surrounded by exquisite gardens and fountains.
For information about Baha'i worship services near you, visit our Prayer and Devotions page.
More information
Visit the new official site of the Baha'i Temple.
Follow the Baha'i House of Worship on Facebook
Subscribe to the Baha'i House of Worship eNewsletter


text:
Thursday, 01 August 2013 00:00
The Over the Hill Gang Softball league is holding its annual Charity Night on Friday, Aug. 2 at Allen Park on Motor Avenue in Farmingdale. Proceeds from this year's event will go to a sweet baby named ElieAnna. She was born with a rare liver disease. She has already undergone several surgeries including a liver transplant and is being treated for a serious post operative condition. EllieAnna's mom grew up in Farmingdale and her dad is a U.S. Marine. The festivities begin at 7 p.m. and will include music, refreshments and raffles.
In game action last Friday, Zwanger-Pesiri Radiology picked up a much-needed win with a 27-7 victory over McCourt & Trudden Funeral Home. M&T played with only three outfielders, which helped ZP find some open spaces, but ZP's bats were hot regardless. The team banged out 30 hits. Jerry Mazza had four.
Tommy Dittmeier, Bino Reverberi, Sean O'Flynn, and Anthony Nicolich had three hits. John Hernandez, Russ Graham, Tyrone Clark, John DeFalco, Brian Tinney and Peter Mendelson chipped in two hits a-piece.
Pitcher Tinney was helped with several infield double plays, O'Flynn at 3rd, Graham at shortstop and both Hernandez and Nicolich at 2nd base all played well. Dittmeier had a brief cup of coffee at first base and appears to be welcoming his return to the outfield next week.


text:
Reviews for You're So Last Summer LyricsPerformed by Taking Back Sunday
By Pages: 1 2 3 4 Current page No. 3/ 4
Add Your New Review About The Song
deep as the pacific | Reviewer: emily Pierce | 8/1/07
This song really is quite poetic I think. I take it to be him saying in the lyrics what a girl is saying about him. I mean, isnt it so typical for a girl to think a certain guy she has dated is over-rated, yet still want to know they will be missed? Anywho...I think it has meaning and its cool with me.
freaky.. | Reviewer: Anonymous | 7/17/07
this song gets the freak out of me!! yeah, i'll recommend this to my friends.
wow haley | Reviewer: jorgy | 6/18/07
wow yo u call that other girl a poser but timberwolves in new jersey was off of the album tell all your friends so yeah die.
kool awesome! | Reviewer: bevin | 4/19/07
um.. i dont fully get the point of this song... yeah i think its about they broke up and hes telling her that he hopes that shes missing him ? and that she hates him?
thank you
Hahaha... | Reviewer: Haley | 3/15/07
Look at that poseur who wrote 'lol' at the end of her review. What an idiot. Go home, stop leaving pointless reviews, eh?
But anyway, TBS are really amazing. I love the "If I'm just bad news, then you're a liar" part, though my favorite song off Where You Want to Be is Timberwolves at New Jersey.
Amazing. | Reviewer: mckenziee | 3/14/07
This song and this band are absolutely uh-mazing.
wow | Reviewer: SeanP | 3/14/07
amazing song, and yes amazing CD. This song, cute without the "E", and there's no "i" in team are my favourites
chris | Reviewer: chris | 2/13/07
I LOVE TBS AND THERE LYRICS....and i kno this song by a heart and others but yah this is my fav song by them..and i went to the warped tour it was awsome
bebe koh,azie... | Reviewer: zieanne | 2/20/07
well the video was so nice...this guys was the freakest of all the singers that i was on thier music video..the teeth ofthe vocalist wa s so discusting...but meaningful and heart touching..keep on rockin`..
love tbs | Reviewer: Anonymous | 10/23/05
i love these guys i got to go to warped tour the summer before last and got to meet a few band mambers but not adam :( i got pics from the pit and this is posible one of my fav songs cause it is simple and the lyrics are killer
Add Your New Review About The Song
By Pages: 1 2 3 4 Current page No. 3/ 4


text:
Return to Forum
I just started watching. I love that when they got to the US there was a language barrier
May 9 2010 at 6:01 PM
Registered Users
Response to
AR... ok, now i don't want the brothers to win... go cowboys!! nt
Frigging cab drivers lol
Respond to this message
LOL... that was funny and........
- dianamite on May 9, 2010, 6:03 PM
Jeff won the Cootie Taw and re-evicted the lesbians! nt
- TemporaryName on May 9, 2010, 6:15 PM
lol go jeff !! i wonder what she'd be like if she was even more pizzed off ?? nt
- dianamite on May 9, 2010, 6:17 PM
I confess I didn't really care who won after Jorff left nt
- TemporaryName on May 9, 2010, 6:22 PM
Me 2 Di nt
- rooo @ work on May 10, 2010, 5:07 AM
Copyright © 1999-2014
. All rights reserved.
Terms of Use
Privacy Statement


text:
Carmine's - 91st Street - NYC
- Address:
2450 Broadway
New York, NY 10024Neighborhood:
Upper West Side
- Cuisine:
ItalianPrice: $30 and under
Carmine's - 91st Street - NYC
- Dining Style: Casual Dining
- Website: http://www.carminesnyc.com/
- Phone: (212) 362-2200
- Hours of Operation:
Dinner: Sunday - Thursday: 11:30am - 11:00pm; Friday - Saturday: 11:30am - Midnight
- Payment Options: AMEX,Discover,MasterCard,Visa
- Cuisine: Italian
- Executive Chef: Joe Delgado
- Dress Code: Casual Dress
- Accepts Walk-Ins: Yes
- Additional Details: Banquet/Private Rooms, Bar Dining, Bar/Lounge, Beer, Cafe, Delivery, Full Bar, Non-Smoking Restaurant, Patio/Outdoor Dining, Personal wines welcome, Personal wines welcome (corkage fee applies), Private Room, Takeout, Wine
- Catering: Let Carmine's Cater your next party. We offer full service catering for all types of events. Let us drop off and setup or let us stay and serve your guests with the Carmine's experience at your door. Contact our Catering Department at 212-362-6444.
- Special Events: Host your party where the Carmine's tradition began. The Little Room is the perfect setting for intimate gatherings, business meetings, rehearsal dinners or other social get-togethers. Our Executive Chef has created four course menus that are served at one long table. The Little Room seats up to 40 guests.
Our main dining room boasts a massive mahogany bar, vaulted ceilings, and cathedral chandeliers. This former ballroom is quintessential New York and is ideal for private parties and special events. This pioneer of the Upper West Side can host a seated dinner, served family style, for up to 300 guests. Celebrate Bar and Bat Mitzvahs, weddings, corporate dinners, or fundraisers. We've designed special menus for cocktail and buffet receptions for up to 350.
Celebrate special occasions in the fun, festive atmosphere that is Carmine's.
Contact our Special Events Department at 212-721-5587.
A word from Carmine's - 91st Street - NYC
Carmine's simple and very popular concept is to serve every meal in the style of an Italian American wedding feast - which means large portions of home-style antipasti, pastas, seafood and meat entrees served on large platters designed for sharing. And when we say large, we mean large. An entree here could easily feed three to four average eaters. Located in a sprawling, former grand ballroom on the Upper West Side of Manhattan, this is the original Carmines. Designed by Peter Niemitz, the interiors evoke the images of the quintessential New York restaurant. With elements and details from the 1920s to the 1940s, the restaurant has the look and feel of a place that has been around for much longer than it's 1990 opening. If you are in the market for freshly prepared family style Italian food that is served in huge portions at reasonable prices, this is the place for you.Continued
Foodspotting photosSee all photos
Carmine's - 91st Street - NYC reviews from OpenTable diners
272 reviews since August 1, 2014
- Food4.5Service4.3
- Ambiance4.1Noise LevelEnergetic
good for groups (227)special occasion (122)fit for foodies (111)kid-friendly (110)neighborhood gem (97)great for lunch (71)hot spot (52)romantic (30)late-night find (26)great for brunch (25)notable wine list (25)great for outdoor dining (16)vibrant bar scene (16)scenic view (10)Show More
- OpenTable Diner Since 2014Dined on 11/24/2014Great service, great wait staff. And of course the food is outstanding.Special Features:
- Go with a hungry group!OpenTable Diner Since 2008VIPDined on 11/23/2014Really good food, wonderful service and fun, lively atmosphere. The portions are enough for six, so bring friends or plan on lots of leftovers.Special Features:I would recommend this to a friend.
- Delicious!!OpenTable Diner Since 2013Dined on 11/22/2014Food was outstanding, very delicious!! It's very noisy.. Fun with a large group.Special Features:I would recommend this to a friend.
- Terrible Wait Staff this time.RayRodDined on 11/22/2014I've gone to the Carmines restaurant uptown, many times. The food has always been excellent, as well as the service. However, all good streaks come to an end I suppose. Our waitress was friendly and seemed ok at 1st, but after taking our drinks order, and appetizer order, things went dowhill from there. (we were provided our appetizer/salad 1st and then had to ask the waitress for bread). After the salad arrived our waitress advised she was leaving for the night, and "that guy over there will be taking over our table". We wanted to place our order at that point and asked if she was able to take it, which she accomodated. "That guy who was taking over our table was no where to be seen, and never made an attempt to introduce themself as the cover for our previous waitress. Not once did he come by to check if we needed refills on our drinks, or bottled water, but he was aware enough to check on the tables to the left and right of us. The staff who assisted and brought the bread, salad, and entrees were MUCH more useful than this waiter who was filling in and supposedly our waiter now. Luckily our food, came out, which meant the waitress we initially placed the order for us....we were reluctant she got the order in as she seemed to be in a rush to get off her shift. But the waiter who covered for her afterwards did absolutely NOTHING. Oh, actually he did, he came by and asked if we wanted desert....No thanks buddy, just get us the check so we can get outta here. I'll be back, but i won't settle for that kind of service at Carmines again, as I was trying to be patient with my girlfriend while trying to enjoy her birthday meal, and didnt want to make a stink as we were having a good time aside from the non-existent waiter. If we ever get that waiter again, i'll ask to be seated elsewhere, or for another waiter.Special Features:I would recommend this to a friend.
- I enjoyed the family style dining !GfamDined on 11/16/2014The food was great and our waiter, Raheem, was wonderful ! 😃Special Features:I would recommend this to a friend.
- Awesome!slw422Dined on 11/16/2014Awesome food! Awesome food! Did I mention the food was great! I would recommend to anyone that loves real Italian food.Special Features:I would recommend this to a friend.
- tablefor2Dined on 11/16/2014Family style meals, more than you can eat. Not the best for only two but the food was still very good and the service was great.Its more fun with a group to share different dishes with, they are all good. Very attentive from the start right to the take home bag. Save the waiting time and make a reservation.Special Features:I would recommend this to a friend.
- Bring Family and friends, plenty of Delicious FoodChuckMDined on 11/16/2014Five of us went there for lunch on a Sunday and we ordered a Pasta order and a Chicken order. The waiter said the meals were meant to feed 4 - 6 people so our size group was perfect. I think there was enough food to feed about 8 people, they are generous with the portions and the food tasted fresh and delicious. Definitely the Italian style of serving, loads of food for all, which we liked a lot. The atmosphere is relaxed, restaurant has a lot of energy as you would expect and it is a fun place to go. I would recommend it, but be sure to bring plenty of family and friends or be prepared to bring home some of the food.Special Features:I would recommend this to a friend.
- Great food!LewlewDined on 11/15/2014So my party and I showed up a half an hour late. We thought we would have to wait seeing as we were late. They sat us right away no questions asked no problems. There were six of us we order so much food we tried are best to eat it all, it wasn't happening. The good was amazing we just have bigger eyes then stomachs. I loved their chicken it's always cooked perfect. Their steak and potatoes were on point as wellSpecial Features:I would recommend this to a friend.
- Saturday night dinneral7sDined on 11/15/2014I made a reservation for three people for 7p.m. and it's a good thing I did because it was PACKED! We were seated around 7:10/7:15. We ordered the baked clams as an appetizer-Soooo GOOD! The serving came with about ten pieces and we easily could have devoured another ten! Just delicious. Upon the server's recommendation we ordered the chicken parmigiana which was really good. It was very loud in the restaurant due to the sheer volume of people (and thus kind of cramped as well) but the food was well worth the noise and crowdedness. Summary Great place to share food Make a reservation (and come on time or else they may give away your table!) Get the baked clams :)I would recommend this to a friend.
- Every night is a partyNeilVIPDined on 11/15/2014If you have a big group looking for casual fun and excellent food, this is the place.Special Features:
- A must try!TopazDined on 11/15/2014Our meal started with a wonderful appetizer, the calamari is the best I've ever had! The Carmine's salad was fresh and delicious, the lasagna was good but I'd prefer without meat, or sausage instead of beef, but still a great dish. Love the family style and large portions. We had left overs and our party of 4 was definitely satisfied!Special Features:I would recommend this to a friend.
- DisappointingRichardRDined on 11/15/2014This was my first time at this location of Carmine's and it was a major letdown.
- ModeloDined on 11/13/2014GREAT SERVICE BY SEAN AND FOOD WAS GREAT...THE ONLY THING I DIDNT LIKE WAS THAT THE SALAD AND CALAMARI WAS MEANT TO COME OUT TOGETHER BUT SALAD CAME OUT QUICKLY BUT THE CALAMARI TOOK AWHILE TO COME OUTSpecial Features:I would recommend this to a friend.
- never a complaint from about carminesgmadDined on 11/12/2014The atmosphere, food, the servers, the other people make carmine's a great restaurant to eat atSpecial Features:I would recommend this to a friend.
- Busy Even at 6pmYumjDined on 11/9/2014Very busy, vibrant place. The food is served family style with huge portions. The servers were helpful and the food was good. Would go again.Special Features:I would recommend this to a friend.
- 58AvenueDined on 11/8/2014Great food and service. Perfect for a party of 6 because the food is serviced family style.Special Features:I would recommend this to a friend.
- DisappointingOpenTable Diner Since 2009Dined on 11/8/2014I was very disappointed at the service and the quality of the food for this well-known restaurant. It has become too much of a factory style eatery and less of the authentic Italian cuisine you'd expect. We received wrong food, rushed service, inaccurate bill. It was far too much of a headache to have enjoyed the experience. Carmine's doesn't really care if you and your family have a good dining experience.Special Features:
- Excellent!Dawn197Dined on 11/8/2014Kids love coming here when we visit NYC!! Food is abundant and fresh!Special Features:
- Big Parties, book more!MariaDined on 11/7/2014Good food and a lively environment. I would recommend for large groups, but book at least 1 week in advance. My advice would be to overbook, and take away if someone cancels, as they are not open to adding to your reservation, even at 2 or 3 days prior. Very busy! Fun place you don't have to worry about being loud, as the whole ambiance is energetic.Special Features:
- Always love Carmine'sBarbaraDined on 11/5/2014I have been to all locations of Carmine's. Every time the food is delicious and the service is great. Highly recommend , especially for a large group. There were 6 of us and we all enjoyed every course.Special Features:I would recommend this to a friend.
- YummyDined on 11/4/2014It has ALWAYS been one of my favorite eateries since the early 90's. The place to share great food mixed with great drinks and your best of friends and/or family. The atmosphere raises your energy to complete the day. There are great food selections and have always been consistantly DELICIOUS and plentiful. I just love it there.Special Features:
- West side institutionTipsyDined on 11/2/2014Energetic family restaurant ! Good for groups- huge portions but great food- fun!Special Features:
- Family diningKristinaDined on 11/2/2014This is a restaurant were you order groupwise, one dish serves 3-4 persons if you combine it with a choice of pasta. So it is very affordable. Wine is served in ordinary water glasses, wich is explained to be the typical Italian way. Not true to our knowledge, but if you ask kindly you can get a cognac snifter for your wine.Special Features:I would recommend this to a friend.
- Carmine's is Great!datzitDined on 11/2/2014Carmine's has always been a favorite. They continue to deliver the same quality of service and food as they did when they first opened. I have had many memorable dinners here. Thank you!
- joyce23Dined on 11/2/2014Carmines had typical Italian American cuisine. It did not differ from a neighborhood pizza place. The sausage was bland; the manicotti was nothing out of the ordinary. There was too much garlic in the salad and too much salt. I tasted the garlic for over a day and I drank a lot of water. The prices were high for the quality. Being Italian, having travelled to Italy many times, and having relatives and friends from Italy, I could not recommend this restaurant to them.Special Features:
- New York City Marathon PreRace MealKcv66Dined on 11/1/2014If your in a hurry don't go when it's busy. The wait is worth it and the energy is fantastic. Bring a big appetite the portions are huge family style and the flavors are amazing. Chicken scarpariello was awesome. Bread pudding is the best I've ever hadSpecial Features:I would recommend this to a friend.
- Dinner before Book of MormonJimODined on 11/1/2014Great way to start the experience. Tried to get into the midtown location but couldn't get reservations. It was well worth the trip tot he upper Westside. The garlic bread with parmesan was great! The Pasta and meatballs were very good, the shrimp parmesan was even better ant the veal masala was OUTSTANDING! Veal was extremely tender and the sauce with mushrooms was the best I have ever eaten (this was not the first time I have ordered this meal at Carmine's). The cannoli desert was a great way to end this fabulous dinner. Great service!!Special Features:
- 11.1 visit to Carmine's yumOpenTable Diner Since 2010Dined on 11/1/2014Service was fast and friendly. He understood we had kids and fed them first will come again. Had the amazing garlic bread and chicken parm as well as rigatoni country style. Delish!!!!Special Features:I would recommend this to a friend.
- wonderful meal loved it great staffBevoDined on 10/31/2014Great cesar salad with tangy anchovies shrimp parm yummy pasta white clam sauce rich lots of clamsSpecial Features:I would recommend this to a friend.
- Couples beware...DBBvisitorDined on 10/31/2014Unfortunately we made the mistake of going back to Carmines a second time as a couple thinking we could relive our first visit.... sadly we were wrong. We were given a table for two tucked away in the corner and were treated as an inconvenience as the attention is certainly placed on larger tables and groups. The service was lackluster and the busboy was more attentive than our waiter. Ordering food for two people at Carmines is not to be recommended as the portions are so huge that you cannot have more than two dishes or you will end up wasting most of it, although you can have the leftovers packed to go. As we are visiting and moving on to Halloween festivities we were not in a position to take food away.Special Features:
- dinnerNunnaDined on 10/30/2014Spoke to deserae on the phone informed her I was going to be late she automatically have me a second reservation which was amazing, the welcoming as I eneteted with my family was amazing since I had my sister visiting from Lexington NY , they don't have restaurants like Carmine's there. I will always come back to this Carmine's. Great food . Amazing people. Best food ever! Even though it is loud but hey we are in NYC. Thank you all and everyone !!!Special Features:I would recommend this to a friend.
- Nice experienceEnjoyableDined on 10/30/2014Good food and service. Hope to return when I am again in the neighborhood.Special Features:
- EhKyeeDined on 10/29/2014I've been here a bunch of times. When I was here recently I was made aware that the severs normally make the plates. I was disappointed and slightly offended by this because not once has that been done for me nor was it done the last time I was there. If this is something carmines does it should be done all the time. Food overall was good. Penne al la vodka was a salty. But I'll come back.Special Features:I would recommend this to a friend.
- always a pleasureOpenTable Diner Since 2010Dined on 10/29/2014carmine's never fails to impress. It is cozy, unassuming. Food is always good, and hearty. Will always return to Carmine'sSpecial Features:I would recommend this to a friend.
- Excellent food & Service...MrWinsloweDined on 10/28/2014Excellent food & service... A true dining pleasure.. The calamari is to die for... Frozen Cosmo topped it off..Special Features:I would recommend this to a friend.
- Fun for allkasirishDined on 10/25/2014Great food and service once seated! If you are on a tight schedule or will have hungry or impatient children, especially on a weekend evening, make your reservations EARLY - we were seated 30-60 minutes after our reservation time. Felt like a new restauant trying to figure out their business until we were seated, even then the servers took care of tables on the run.Special Features:
- Good for groups.Luv2travelDined on 10/25/2014Marvelous menu selection . Enable large group to consider various choices to share. Wait staff professional and experts at making recommendations .Special Features:
- Consistently excellentMBtravelDined on 10/24/2014My friend's and I have been going there for years. It's usually around 10 of us. What is great is that they have round tables to accommodate a party of our size which makes it easier to converse with everyone- not just the person sitting next to you. The food is always outstanding and the portions are very large and meant to be shared. The price point is extremely reasonable. This is still one of my favorite restaurants anywhere!Special Features:I would recommend this to a friend.
- Love Carminesluv2dineDined on 10/24/2014Great service, great family sized portions. Nice area.Special Features:I would recommend this to a friend.


text:
Friday, 10 July 2009 00:00
On June 27-28 the Levittown Athletic Club Slammers set out to do something no other LAC 14U team has ever done: win the Babe Ruth State Championship. In the opening game the Slammers defeated Babylon by a score of 10-0 followed by a 5-1 win against host Glen Cove.
On Sunday the Slammers came up against the Pelham Bay Belles, needing one win to advance to the championship game on Monday night. The Slammers rose to the occasion and defeated the Belles by a score of 6-1 to advance to the championship game against Pelham Bay.
In the final game the Slammers jumped out to a one to nothing lead in the third inning on a base hit by Shamar Sanchez followed by a ground out and then an RBI single by Sabrina Gordek. Pelham answered by scoring three runs in the fourth inning on a couple of walks, a two run triple, and a sac fly. LAC would counter in the bottom of the fifth with a couple of base hits followed by a three run homerun by Sabrina Gordek to knot the score at 4. The team traded outs in the sixth inning. In the bottom of the seventh Sabrina Gordek and Ashley Massoni led off with a pair of singles. Up to the plate came the Slammers big bat, Sam Basile, who had delivered a long three run homerun in the previous game, but Basile went down swinging for the first out. Up to the plate came Alannah Basile with a chance to win the game. With the count no balls and one strike, Alannah delivered a line drive over the outstretched hands of the third baseman scoring Sabrina Gordek from second base with the winning run. Slammers Win.
Leading the way all weekend was the stellar pitching of Ashley Massoni who complied thirty-three strikeouts in four games. With First place finishes in Suffern and Glen Cove, a second place finish in the LAC Spring Bash, and a third place finish at The Great Balls of Fire tournament (third out of 22 teams) the Slammers have complied a season record of nineteen wins and three losses.
The coaching staff is extremely proud of the hard work and sportsmanship of each and every girl, and the support of all the parents (The Slammer Nation). Next up, the Mid-Atlantic Regional Tournament in Hamilton, NJ July 17–20.


text:
O Holy Saint Jude, Apostle and Martyr great in virtue and rich in miracles, near kinsman of Jesus Christ, faithful intercessor of all who invoke Your special patronage in time of need, to You I have recourse from the depth of my heart & humbly beg to whom God has given such great power to come to my assistance. Help me in my present & urgent petition. In return, I promise to make Your name known & cause You to be invoked
Say three "Our Fathers", three "Hail Mary's" and "Glories Be's". Publication must be promised. This Novena has never been known to fail. Saint Jude, pray for us & all who invoke Your aid.
Copyright 1997-99 by Most Holy Trinity Church, All Rights Reserved
Send general comments and/or questions to firstname.lastname@example.com
Site design by Pomfret Computer Technologies


text:
Famous quotes by Robert Greenleaf:Sort:PopularA - Z
|Good leaders must first become good servants.
|Many attempts to communicate are nullified by saying too much.
Share your thoughts on Robert Greenleaf's quotes with the community:
Use the citation below to add this author page to your bibliography:
"Robert Greenleaf Quotes." Quotes.net. STANDS4 LLC, 2014. Web. 20 Nov. 2014. <http://www.quotes.net/authors/Robert Greenleaf>.


text:
Araceli (Shelly) Reyna is a Senior Managing Consultant for BKD, LLP's Cost Segregation Group. She has worked for more than 21 years in the cost segregation and construction industries. She works with clients in a wide variety of industries to improve their tax depreciation resulting from studies of new and/or existing buildings; buildings undergoing renovation, restoration, remodeling and leasehold improvements; and building acquisitions.
She has held numerous leadership positions within cost segregation. Prior to joining BKD, Araceli spent 10 years with Price Waterhouse/PriceWaterhouse Coopers, managing their nationwide Cost Segregation Group. In 1994 Araceli received an Associate Degree in Architectural Technology and a Bachelor of Science degree in Construction Technology, from Purdue University Calumet in Indiana. She has presented on Cost Segregation for various Continuing Education courses and Tax Institute seminars.
Araceli's Most valued Purdue Calumet experience:
"My Purdue Calumet experience was the stepping stone to a higher ground of excellence in my life – both personally and professionally. Personally I met many great people and professors who positively impacted my life and professionally it prepared me for a successful career that I have enjoyed for over 21 years. Over the years I have recruited 8 people from Purdue's School of Technology Construction department because I believe the program grooms the best and the brightest."
Araceli's advice for current Purdue Calumet Students:
"Make education a priority in your life not just an option; in the end, it will lead to many options in your life! "


text:
cc'); } -->
2 bed, 2 full bath. TURNKEY FURNISHED AND CLOSE TO THE BEACHES! This home has been a wonderful home to snowbirds and caMore info
2 bed, 2 full bath. Bright open and spacious ground floor condo with enclosed lanai area minutes to Anna MariaMore info
1 bed, 1 full bath. large 1 bed, near bus line, great location, great price, Tenant has given noticeMore info
2 bed, 2 full bath. This condo is beautiful!!! All redone!! 1st floor unit with 2BR and 2BA and nothing left to do!! SuMore info
2 bed, 2 full bath. 4th Floor Ironwood 2/2 condo with Eastern golf course views of #1 Green and #2 Tee Off. The unit coMore info
2 bed, 2 full bath. Stunning in every way, this former Builderâs model is sure to delight! Architectural Digest ready,More info
3 bed, 2 full bath, 1 half bath. Beautiful 3 BR 2. 5 Ba condo located in amenity rich community. Great location and quick access toMore info
1 bed, 2 full bath. This ground floor one bedroom, two bath unit offers a beautiful view of the golf course as well asMore info
2 bed, 2 full bath. IMMACULATE TUCKED AWAY COMMUNITY OFFERING A BEAUTIFULLY UPDATED 2 BR 2 BA CONDO WITH LARGE WALK INMore info
1 bed, 1 full bath. Must see!!!!! Enjoy the Florida lifestyle. Take elevator or stairs up to the 3rd floor that lets ouMore info


text:
Rap star Fat Joe has reported to federal prison in Florida to serve a four-month sentence for tax evasion.
An attorney for the performer, whose real name is Joseph Cartagena, said his client surrendered Monday at a federal detention center in Miami.
Cartagena pleaded guilty in December 2012 to failing to pay taxes on more than $1 million of income in 2007 and in 2008.
Deen case dismissed
A federal judge signed off Monday on a deal to dismiss a discrimination lawsuit against celebrity cook Paula Deen.
A civil lawsuit accusing the former Food Network star and her brother of race discrimination and sexual harassment was officially dismissed when U.S. District Court Judge William T. Moore Jr. in Savannah approved a deal reached by attorneys in the case last week.
Its a girl for Baldwin
Actor Alec Baldwin's wife has given birth to a baby girl in New York.
Hilaria Baldwin tweeted the news from her Twitter account Friday night. She says that the family is overjoyed and that Carmen Gabriela is absolutely perfect.
Baldwin is the father of a 17-year-old daughter, Ireland, from his previous marriage to Kim Basinger.
Butler cleans up
The top five movies from the weekend box office:
1. Lee Daniels' The Butler, $16.5 million
2. We're the Millers, $13 million
3. The Mortal Instruments: City of Bones, $9.3 million
4. The World's End, $8.8 million
5. Planes, $8.6 million
Happy birthday
Among celebrity birthdays today: Actor Tommy Sands is 76. Musician Daryl Dragon is 71. Actor G.W. Bailey is 69. Actor Paul Reubens is 61. Actress Diana Scarwid is 58. Gospel singer Yolanda Adams is 52. Singer Colt Ford is 44. Actress Chandra Wilson is 44. Actress Sarah Chalke is 37. Actor Aaron Paul is 34. Actor Patrick J. Adams is 32. Singer Mario is 26.


text:
Embark on a 21-day financial fast - and then GIVE!
When a tragedy such as the Haiti earthquake occurs, the outpouring of support for this already poor nation is nice to see. As we approach the season of Lent, it can be an extremely spiritually rewarding practice to give some time to reflect upon the way that many people in the United States and elsewhere consume more than we need. On NPR online, Michelle Singletary proposes a 21 day financial fast in order to purify our consumerist mentality. Pairing this practice with the practice of radical giving to the victims of the Haiti earthquake would be good news indeed.
Singletary's 'Power To Prosper' Budget Plan
From NPR.org
Washington Post personal finance columnist Michelle Singletary invites you to start 2010 right by curbing the need to consume. She lays out a 21-day financial fast to curb debt and stress in her book, The Power to Prosper.
. . .
Coming out of the holidays in an economy that can hardly be called a boom, a lot of us could use some help getting a better grip on our finances. That's what drives Michelle Singletary. Her personal finance column The Color of Money is carried in more than 100 newspapers across the country. She's the author of two bestselling books on personal finance, and her latest book is called, "The Power to Prosper: 21 Days to Financial Freedom."
In it, she lays out what she calls a financial fast.
Having fasted, the followup question is also important. What form should your giving take, to whom should you give, what NOT to do?
Here's some solid advice:
There's another we can do: encourage our government to grant Haitians in the U.S. Temporary Protected Status. Go here to see explained and how you can advocate for it:
Glad to report that the Obama administration has now done just that:
"The Obama administration extended a special immigration status on Friday to Haitians living illegally in the United States that protects them from deportation for 18 months and allows them to work here."


text:
Einar Joseph Madsen of Bayville died on Nov. 17, 2013, at age 74. Beloved husband of Dolores. Loving father of Joseph (Lenore), John, and Christine Ambrosino (Anthony). Cherished grandfather of Anthony M., John C., Joseph, Michael, Christopher, Marc, Anthony, and John. Dear brother of Mae Macaluso (Marty), and Robert (Angela) and the late Doris Grover, and Alice Costello. Also survived by loving nieces, nephews, relatives and friends. Visiting Oyster Bay Funeral Home, 261 South St., Oyster Bay. Funeral Mass held at St. Gertrude RC Church, Bayville. Interment Locust Valley Cemetery.www.oysterbayfuneralhome.com
On Oct. 25, 2013, Mary Coronesi Blackwell passed away on her 93rd birthday, after living almost all of her life in Oyster Bay. She is survived by two daughters, Georgia Sinnott and Francine Lewis; six grandchildren, Cheri Turner (Michael), Thomas Sinnott Jr. (Maureen), Sabrina Morenberg, Gabriel Brown, Taylor Lewis, and Hunter Lewis; six great-grandchildren; a brother, Alfred Coronesi, and numerous nieces and nephews. Burial was private.
She will be greatly missed by her family, loving friends, and numerous bingo buddies.
Danielle J. Frasca died suddenly on Nov. 10, 2013, at age 43, of Bayville. Beloved daughter of Dolores and the late John Frasca. Memorial visitation Oyster Bay Funeral Home, 261 South St., Oyster Bay. Memorial Mass at St. Dominic RC Chapel, Oyster Bay. Private cremation with interment at Locust Valley Cemetery at a later date. www.oysterbayfuneralhome.com
Samuel J. Roberto died on Nov. 12, 2013, age 86, of Glen Cove. Beloved husband of Ann. Loving father of Diane Yatauro (Bernie), Laraine Roberto (Gerry), and Richard Roberto (Carol). Cherished grandfather of Michael, Joseph, Noelle, and James. Dear brother of Victoria Giglio (Vincent). Also survived by loving nieces, nephews, relatives and friends. Visiting Oyster Bay Funeral Home, 261 South St., Oyster Bay. Funeral Mass of St. Rocco RC Church, Glen Cove. Interment Locust Valley Cemetery. In lieu of flowers donations to St. Francis Hospital, 100 Port Washington Blvd., Roslyn, NY 11576 would be appreciated. www.oysterbayfuneralhome.com
Virginia Elizabeth Kavash Metz, 90, formerly of Hatfield, PA, passed away in peace Nov. 5, 2013 in Manhasset, surrounded by family. She was the wife of the late Stanley Wyatt Metz, of Kulpsville, who passed away in 1999.
Born July 3, 1923 in Norristown, she was the daughter of the late Elizabeth Haitsch and John Joseph Kavash, founder of the Lansdale Symphony Orchestra.
Elizabeth B. Gassett died on Nov. 1, 2013, at age 77, of Lantana, FL. Beloved wife of the late Harry. Loving mother of Guy (Patti), and Victoria Cotroneo (Angelo). Cherished grandmother of Lauren, Dylan, Angelo Jr., and Nicole. Dear sister of Russell Serrante (Frieda), Mary Ann Fisher, Patricia Serrante, and Christine Maher. Also survived by loving nieces, nephews, relatives and friends. Visiting Oyster Bay Funeral Home, 261 South St., Oyster Bay. Funeral Mass held at St. Gertrude RC Church, Bayville. Interment Mt. St. Mary's Cemetery. wwww.oysterbayfuneralhome.com
Marion P. Andersen, 88, of Smithtown (formerly of Oyster Bay) died on Oct. 25, 2013. Loving Mother of Aina (James) Macomber, Carin (Tom) Andersen, Carl (Lillian)Andersen Vicki Andersen and the late John R. Andersen. Dear grandmother of John Robert, James, Scott, Sarah, Deana, Travis and Patrick. Adored great-grandmother of Drew, Xavier and the late Rylee. Friends may call the St. James Funeral Home, 829 Middle Country Road, St. James (Route 25). In lieu of flowers, donation to the Guide Dog Foundation.
Mrs. Andersen's funeral arrangements were professionally supervised while the Andersen Families were lovingly cared for during their bereavement by Kenneth, Kerry and Ken Jr., the Maher Family of the St. James Funeral Home, in St. James.
Marshall Trout of Huntington, died on Oct. 23, 2013 at age 77. Beloved husband of Estrella. Loving father of Eric (Kim) and Darlene Selario (Frank), Martha and Raquel. Cherished grandfather of Jennifer, Frankie and Samantha. Proud Marine Corps Veteran. Member of the Masonic Lodge. Arrangements made by Dodge-Thomas Funeral Home, Glen Cove. Interment private.
Dr. Saundra W. Simonee died tragically on Sept. 27, 2013, at age 59, of East Norwich. Survived by loving family and friends. Visiting Oyster Bay Funeral Home, 261 South St., Oyster Bay. Funeral Mass St. Dominic RC Church, Oyster Bay. Interment Pine Hollow Cemetery, Oyster Bay. In lieu of flowers donations to Christine Weston, 62 Spencer Place, Hempstead, NY 11550 for The Dr. Sandra Simonee Fund. For further information visit www.oysterbayfuneralhome.com
Manuella J. Keller died peacefully on Oct. 13, 2013, at age 85, of Bayville, formerly of Hollis, NY. Beloved wife of the late Edward. Loving mother of Dean (Jeanne), Mark (Mary), and Paul (Maggie). Cherished grandmother of MAK, Amanda, and Maxwell. Dear sister of Joan Callaghan (James), and Kathleen Ranc (Ronald). Also survived by loving nieces, nephews, relatives, and friends. Funeral Services are Private. Funeral Arrangements entrusted to Oyster Bay Funeral Home. www.oysterbayfuneralhome.com
Page 14 of 68<< Start < Prev 11 12 13 14 15 16 17 18 19 20 Next > End >>